Agilent Technologies Inc. (NYSE: A) is the world's premier measurement company and a technology leader in chemical analysis, life sciences, diagnostics, electronics and communications. The company's 20,000 employees serve customers in more than 100 countries. Agilent had net revenues of $6.6 billion in fiscal 2011.
Agilent's Life Sciences and Chemical Analysis (LSCA) group is a world leading provider of instruments, supplies, software and services to life science and chemical analysis markets. In 2002, these markets accounted for approximately 40% and 60% respectively of LSCA's $1.1 billion in revenue. Agilent LSCA is a global organization with 3,700 employees, five international manufacturing sites and worldwide sales and support services.
The mission of Agilent LSCA is to enable increasingly innovative and productive research in pharmaceutical, biotech, academic, government and corporate organizations. LSCA's key technology platforms include liquid chromatographs, gas chromatographs, microarrays, mass spectrometers and microfluidics-based devices. These technologies enable the identification, quantification, and analysis of the atomic, molecular, physical and biological properties of thousands of substances and products.
Specific focus of company
Agilent Technologies offers a broad range of instruments, laboratory supplies/consumables, and computer-based laboratory systems for life sciences and analytical chemistry research. They include DNA microarrays, microarray scanners, software, and reagents; microfluidic-based sample analysis systems; LC systems, columns and components; capillary electrophoresis systems; purification systems; protein identification systems; mass-spectrometry systems including ICP-MS, GC/MS and LC/MS; gas chromatographs supported by GC detectors; injection systems; sample-handling systems and columns; automated sample-preparation systems; laboratory-computing and data networking systems. Agilent also offers multi-vendor compliance services for pharmaceutical companies.
LSCA Markets Served
As the leading provider of chemical analysis tools, Agilent is developing new products for the growing environmental, petrochemical, food safety and Ag-Bio markets, and supports homeland defense with instruments and expertise in biochemical detection and forensics. LSCA also provides products to the drug testing, fuel cell, and semiconductor markets.
In the life sciences, Agilent is helping organizations unlock the genetic causes of disease and further the discovery and development of new drugs. Agilent addresses the research needs of the entire pharmaceutical value chain with solutions for gene expression, proteomics, informatics, pharmaceutical drug analysis (for drug development, QA/QC, and manufacturing), and regulatory compliance.
Agilent is a world market leader in gas chromatography (GC), GC/MS, liquid chromatography (LC), LC/MS, microfluidics and compliance services, with product and technology leadership in many areas, including gene expression and proteomics analysis. Agilent's technologies are enabling significant advances in chemical and life science research.
Information about Agilent is available at www.agilent.com.
Number of employees: 20000
Main business focus/
Listing by sector:
- Genomics - Laboratory equipment
- Environmental Biotechnology
- Drug Discovery & Development
LSCA's key technology platforms include liquid chromatographs, gas chromatographs, microarrays, mass spectrometers and microfluidics-based devices. These technologies enable the identification, quantification, and analysis of the atomic, molecular, physical and biological properties of thousands of substances and products.
|Contact person||Sue Broughton|
|Job Title||Marcom Specialist|
|Address||679 Springvale Road|
|Phone||1800 802 402|
|Fax||+61 3 9210 5474|